| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.36B | 101.56B | 96.86B | 90.83B | 77.55B | 68.21B |
| Gross Profit | 17.22B | 17.44B | 16.02B | 14.55B | 12.95B | 11.79B |
| EBITDA | 3.52B | 3.97B | 3.47B | 2.65B | 2.42B | 2.89B |
| Net Income | 1.64B | 1.94B | 1.95B | 1.62B | 1.70B | 1.59B |
Balance Sheet | ||||||
| Total Assets | 35.33B | 31.28B | 31.35B | 30.09B | 27.46B | 21.68B |
| Cash, Cash Equivalents and Short-Term Investments | 7.22B | 8.19B | 9.64B | 9.80B | 8.78B | 5.87B |
| Total Debt | 3.81B | 1.53B | 2.07B | 2.52B | 3.01B | 67.00M |
| Total Liabilities | 18.48B | 14.48B | 16.02B | 15.28B | 13.90B | 8.91B |
| Stockholders Equity | 16.56B | 16.50B | 15.06B | 14.57B | 13.56B | 12.76B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.23B | 2.58B | 2.10B | 2.19B | 1.58B |
| Operating Cash Flow | 0.00 | 1.68B | 3.23B | 2.29B | 2.27B | 1.67B |
| Investing Cash Flow | 0.00 | -2.08B | -1.29B | -146.00M | -1.54B | -496.00M |
| Financing Cash Flow | 0.00 | -1.06B | -2.10B | -1.11B | 2.16B | -1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥119.99B | 13.47 | ― | 7.51% | 8.28% | -36.32% | |
73 Outperform | ¥20.81B | 8.06 | ― | 3.09% | 4.92% | -27.88% | |
73 Outperform | ¥9.96T | 21.38 | 27.29% | 0.27% | 1.23% | 26.94% | |
66 Neutral | ¥547.17B | 15.57 | 19.18% | 3.59% | 6.95% | 13.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥60.69B | 12.19 | ― | 3.66% | 3.47% | -0.05% | |
42 Neutral | ¥75.56B | -1,275.30 | -6.02% | 0.77% | -9.70% | -108.59% |